首页> 外文期刊>AJRI: American Journal of Reproductive Immunology >A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
【24h】

A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.

机译:一项前瞻性病例对照研究分析了土耳其夫妇反复流产的12个血栓形成性基因突变。

获取原文
获取原文并翻译 | 示例
           

摘要

PROBLEM: Recurrent pregnancy loss (RPL) is a heterogeneous disorder. The contribution of specific thrombophilic genes to the pathophysiology of RPL has remained controversial. We evaluated the prevalences of 12 thrombophilic gene mutations among homogenous Caucasian couples with RPL and fertiles. METHOD: of study This was a prospective case-control study evaluating 272 women with RPL and 152 of their male partners, and a control group of 56 fertile couples. We investigated mutations including FV Leiden, factor V H1299R, factor II prothrombin G20210A, F XIII V34L, beta-fibrinogen -455G>A, plasminogen activator inhibitor-1, GPIIIa L33P (HPA-1 a/b L33P), MTHFR C677T, MTHFR A1298C, ACE I/D, Apo B R3500Q, and Apo E. RESULTS: Overall, heterozygous mutations of FV Leiden, FXIII V34L, GPIIIa L33P, Apo E4, and prothrombin G20210A and homozygous mutations of PAI-1and MTHFR C677T were associated with RPL. There was no meaningful association between RPL and other studied genes. CONCLUSION: In contrast to the other mutations and polymorphisms, FV Leiden, FXIII V34L, GPIIIa L33P, Apo E, prothrombin G20210A, PAI-1 and MTHFR C677T gene mutations may help to identify the couples at risk for recurrent pregnancy loss.
机译:问题:反复流产(RPL)是一种异质性疾病。特定的嗜血性基因对RPL病理生理的贡献仍存在争议。我们评估了RPL和可育的同性白种人夫妇中12个血栓性基因突变的患病率。方法:研究这是一项前瞻性病例对照研究,评估了272名RPL女性和152名男性伴侣以及对照组的56对可育夫妇。我们研究了包括FV Leiden,因子V H1299R,因子II凝血酶原G20210A,F XIII V34L,β-纤维蛋白原-455G> A,纤溶酶原激活物抑制剂-1,GPIIIa L33P(HPA-1 a / b L33P),MTHFR C677T,MTHFR的突变结果:FV Leiden,FXIII V34L,GPIIIa L33P,Apo E4和凝血酶原G20210A的总体杂合突变与PAI-1和MTHFR C677T的纯合突变相关:A1298C,ACE I / D,Apo B R3500Q和ApoE。 。 RPL和其他研究的基因之间没有有意义的关联。结论:与其他突变和多态性相比,FV Leiden,FXIII V34L,GPIIIa L33P,Apo E,凝血酶原G20210A,PAI-1和MTHFR C677T基因突变可能有助于识别有再次流失妊娠风险的夫妇。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号